Why the study?
The prognostic value of the platelet-to-lymphocyte ratio in critically ill patients with heart failure remained unclear.
Does an elevated platelet-to-lymphocyte ratio predict 1-year all-cause mortality in ICU patients with heart failure?
Does an elevated platelet-to-lymphocyte ratio predict 1-year all-cause mortality in ICU patients with heart failure?
Elevated platelet-to-lymphocyte ratio is an independent predictor of 1-year all-cause mortality in critically ill patients with heart failure, and improves risk stratification when added to standard clinical scores.
No takes yet. Share an insight, caveat, or question.
Should not yet change ICU HF practice; leaves open PLR’s incremental value for 1-year risk models in prospective studies.
Hu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: